Empfehlung zur perioperativen Unterbrechung einer Metformin-Medikation

Literatur

• 1 Chan N N,, Bran H P, Feher M D. Metformin-associated lactic acidosis: a rare or very rare clinical entity? .  Diabet Med. 1999;  16 273-281
• 2 Emslie-Smith A M, Boyle D I, Evans J M, Sullivan F, Morris A D. Contraindications to metformin therapy in patients with Type 2 diabetes - a population-based study of adherence to prescribing guidelines.  Diabet Med. 2001;  18 483-488
• 3 Kruse J A. Metformin-associated lactic acidosis.  J Emerg Med. 2001;  20 267-272
• 4 Lalau J D, Race J M, Andreelli F, Lacroix C, Canarelli J P. Metformin retention independent of renal failure in intestinal occlusion.  Diabetes Metab. 2001;  27 24-28
• 5 Lalau J D, Race J M. Lactic acidosis in metformia therapy: searching for a link with metformin in reports of »metformin-associated lactic acidosis«.  Diabetes Obes Metab. 2001;  3 195-201
• 6 Lovas K, Fadnes D J, Dale A. Metformin associated lactic acidosis - case reports and literature review.  Tidsskr Nor Laegeforen. 2000;  120 1539-1541
• 7 Mercker S K, Maier C, Neumann G, Wulf H. Lactic acidosis as a serious perioperative complication of antidiabetic biguanide medication with metformin.  Anesthesiology. 1997;  87 1003-1005
• 8 Scherbaum W A. Metformin und Anästhesie - wie hoch ist das Risiko einer Laktatazidose?.  Dtsch Med Wochenschr. 2001;  126 607-608
• 9 Wulf H, Mercker S K, Maier C. Specific therapies of biguanide-induced lactic acidosis.  Anaesthesiology. 1998;  89 267-268